drugset / Trial / NCT03198923
Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and effectiveness of natural killer (NK) cell and natural killer T (NKT) cell-based immunotherapy in subjects with non small cell lung cancer.
Timeline
- Start
- 2017-09-13
- Primary completion
- 2018-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | natural killer and natural killer T cell | Unknown | 2e+09 cells | — |
| Subject | natural killer and natural killer T cell | Unknown | 2.5e+09 cells | — |